
Grape
Grape seed extract is a polyphenol-rich supplement with reasonably consistent modest blood pressure-lowering effects in younger, overweight, or metabolic-syndrome adults. Other claimed benefits (venous insufficiency, antioxidant capacity) are biologically plausible but clinically modest. Resveratrol from grape products is a separate compound with its own evidence base.
Quick decision guide
May help most
Adults under 50 with mildly elevated BP or metabolic syndrome who want a low-risk adjunct to lifestyle changes; people with mild chronic venous insufficiency or heaviness/swelling in legs.
Common dosing range
100–300 mg/day standardized to ≥95% proanthocyanidins (OPC); trials have used 100–600 mg/day.
When to expect effects
8–12 weeks for blood pressure changes; weeks for venous-symptom relief.
Watch out for
Mild antiplatelet/anticoagulant activity — coordinate with prescriber if on warfarin or pre-surgery.
Evidence snapshot
What is it
Grape (Vitis vinifera) supplements are typically derived from the seeds, skin, or whole fruit and are rich in polyphenols including proanthocyanidins (OPCs), resveratrol, anthocyanins, and flavonoids. Grape seed extract is the most common supplemental form.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Blood pressure (mild-to-moderate elevation) Good Evidence | ≈3–6 mmHg SBP reduction overall; up to ~8.5 mmHg SBP in metabolic syndrome subgroups; smaller DBP effect (1–3 mmHg) | Adults under 50 with metabolic syndrome, obesity, or prehypertension/stage 1 hypertension | 8–12 weeks at 100–300 mg/day |
Chronic venous insufficiency (leg symptoms) Limited Evidence | Modest reductions in leg edema and subjective symptoms; objective venous-flow improvements in pilot imaging studies | Adults with mild CVI (leg heaviness, evening swelling) who can't or won't use compression stockings | Weeks (8 weeks in most registry data) |
Antioxidant biomarkers Limited Evidence | Reliable increases in plasma antioxidant capacity; clinical translation uncertain | Adults with elevated oxidative stress markers as part of metabolic-syndrome research | Weeks |
Skin elasticity and photo-aging Mixed Evidence | Variable; not robustly demonstrated in adequately powered trials | Adults with photo-damaged skin interested in a low-risk oral adjunct | Not well characterized |
Cognitive function Mixed Evidence | Variable; mostly mechanistic with small acute trial signals | Older adults willing to add it as a low-risk cognitive-support trial | Not established |
Blood pressure (mild-to-moderate elevation)
- Effect
- ≈3–6 mmHg SBP reduction overall; up to ~8.5 mmHg SBP in metabolic syndrome subgroups; smaller DBP effect (1–3 mmHg)
- Best fit
- Adults under 50 with metabolic syndrome, obesity, or prehypertension/stage 1 hypertension
- Time
- 8–12 weeks at 100–300 mg/day
Chronic venous insufficiency (leg symptoms)
- Effect
- Modest reductions in leg edema and subjective symptoms; objective venous-flow improvements in pilot imaging studies
- Best fit
- Adults with mild CVI (leg heaviness, evening swelling) who can't or won't use compression stockings
- Time
- Weeks (8 weeks in most registry data)
Antioxidant biomarkers
- Effect
- Reliable increases in plasma antioxidant capacity; clinical translation uncertain
- Best fit
- Adults with elevated oxidative stress markers as part of metabolic-syndrome research
- Time
- Weeks
Skin elasticity and photo-aging
- Effect
- Variable; not robustly demonstrated in adequately powered trials
- Best fit
- Adults with photo-damaged skin interested in a low-risk oral adjunct
- Time
- Not well characterized
Cognitive function
- Effect
- Variable; mostly mechanistic with small acute trial signals
- Best fit
- Older adults willing to add it as a low-risk cognitive-support trial
- Time
- Not established
Evidence for 5 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Blood pressure (mild-to-moderate elevation)
Biomarker supportA 2016 meta-analysis of 16 RCTs (810 participants) found grape seed extract reduced SBP by ~6 mmHg and DBP by ~2.8 mmHg overall, with the largest effects in younger adults (<50), obese subjects, and people with metabolic syndrome (up to 8.5 mmHg SBP reduction). An earlier (2011) meta-analysis of 9 trials found a smaller SBP reduction of 1.54 mmHg with no effect on DBP. The mechanism is thought to involve increased nitric oxide bioavailability via endothelial-mediated vasodilation.
Bottom line: Worth a 3-month trial as a BP adjunct for younger/metabolic-syndrome adults — but don't replace prescribed BP medication.
Evidence is mixed
The 2011 and 2016 meta-analyses found different effect sizes (1.5 vs 6 mmHg SBP). Heterogeneity is high; the most reproducible signal is in metabolic-syndrome subgroups.
Chronic venous insufficiency (leg symptoms)
Supplement benefitSmall clinical trials and a 4D flow MRI pilot study (Sasaki 2022) show grape seed proanthocyanidins improve venous flow markers and reduce leg heaviness, swelling, and discomfort in mild-moderate CVI. Pycnogenol (pine bark extract) has slightly stronger CVI evidence in head-to-head registry comparisons but uses a similar proanthocyanidin profile. Effects are modest; compression stockings remain first-line.
Bottom line: Reasonable adjunct for mild CVI; don't expect it to replace compression therapy.
Antioxidant biomarkers
Biomarker supportMultiple short RCTs report increased plasma antioxidant capacity (ORAC, FRAP) and reduced oxidative stress markers (MDA, oxidized LDL) with grape seed extract. These are biomarker changes — they don't reliably translate to hard clinical endpoints like fewer heart attacks or longer life. Useful as a mechanistic plausibility check, not a treatment goal in itself.
Bottom line: Biomarker change is real but clinical outcomes are unclear — don't take it just for 'antioxidant boost.'
Skin elasticity and photo-aging
Mechanism onlySmall trials suggest grape seed extract may improve skin elasticity, hydration, and markers of photo-damage. Evidence is preliminary, with short follow-up and small samples. Mechanistically plausible via collagen and elastin stabilization but not established as effective vs placebo at meaningful endpoints.
Bottom line: Sunscreen, retinoids, and dermatology-grade actives have far stronger evidence for skin aging.
Cognitive function
Mechanism onlyMechanistic and small-trial data suggest grape polyphenols may modestly increase cerebral blood flow and acute attention/processing-speed scores in older adults. Trials are small, short, and use varying products. No effect on long-term cognitive decline or dementia prevention has been demonstrated.
Bottom line: Don't take it for dementia prevention; the evidence isn't there.
How it works
How to take it
What to track
Bottom line: 100–300 mg/day of a 95%-OPC standardized product for 12 weeks. Recheck BP at home and reassess; not a substitute for antihypertensive medication if BP is moderate-to-severe.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Grape seed extract (≥95% OPC standardized)
Best studiedThe form used in most blood pressure and venous insufficiency RCTs. Provides concentrated oligomeric proanthocyanidins. Look for products that state the OPC percentage on the label.
Low intact-OPC absorption; many effects mediated by gut microbiota metabolites.
Grape skin extract
Anthocyanin-focusedRicher in anthocyanins than OPCs. Often combined with seed extract for a broader polyphenol profile. Less standalone clinical data than seed extract.
Anthocyanins are absorbed and rapidly metabolized; bioavailability of intact forms is low.
Whole grape powder
Food-like profileFreeze-dried whole grape including skin, seed, and pulp. Lower potency per gram than concentrated extracts but provides a broader polyphenol and fiber profile. Doses typically 500–1,500 mg/day to approximate fruit servings.
Closer to dietary intake profile; lower polyphenol concentration.
Grape leaf extract (Antistax)
Venous-focused (EU)European OTC product for CVI made from red vine leaf extract (Vitis vinifera leaves). Different polyphenol profile than seed extract; head-to-head registry data show modest CVI benefit but slightly less than Pycnogenol.
Distinct from grape seed extract — different active fraction.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Mild antiplatelet activity — could increase bleeding risk when combined with anticoagulants (warfarin, DOACs) or antiplatelets (aspirin, clopidogrel). Discontinue 1–2 weeks before any planned surgery.
Theoretical CYP3A4 inhibition — weaker than grapefruit but possible at high doses. Could modestly affect CYP3A4-metabolized drugs (statins, calcium channel blockers).
Allergic reactions (hives, rash) — rare but reported, especially in people with known grape allergy.
Who should avoid it
- People on warfarin, DOACs (apixaban, rivaroxaban), or other anticoagulants without prescriber coordination.
- People with known grape or wine allergy.
- People scheduled for surgery in the next 1–2 weeks.
- Pregnant or breastfeeding women — safety of concentrated extracts not well established; whole-grape consumption as food is fine.
Pregnancy & breastfeeding
Eating grapes during pregnancy is safe and normal. Concentrated grape seed extract supplements have not been adequately studied in pregnancy or lactation — avoid the extract during pregnancy unless your obstetric provider explicitly approves it. The whole fruit provides similar polyphenols at food-level doses without the concentrated-extract uncertainty.
Bottom line: Generally well tolerated. The main practical concern is mild antiplatelet activity — coordinate with prescribers if on blood thinners or facing surgery.
Interactions
Grape seed extract has mild antiplatelet activity; combination raises bleeding risk. Monitor INR more closely with warfarin and discuss with your prescriber before starting.
Additive antiplatelet effect — increased bruising and bleeding risk. Generally compatible at low antiplatelet doses but discuss with prescriber.
Grape seed extract is a weak CYP3A4 inhibitor (much weaker than grapefruit). Theoretical small increase in CYP3A4 substrate levels (some statins, calcium channel blockers, sirolimus). Mention to prescriber at higher doses.
Additive BP-lowering effect — usually desirable but can cause dizziness if combined with newly started or recently up-titrated antihypertensives. Monitor home BP for symptomatic hypotension.
Additive antiplatelet effect — modest increase in bleeding risk with long-term use of both. Avoid sustained combination unless needed.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Red grapes, raw | 1 cup (151 g, 104 kcal) | — |
| Black grapes, raw (higher anthocyanin) | 1 cup (~110 kcal) | — |
| Grapes — vitamin C | 1 cup (4.8 mg) | 5% |
| Grapes — manganese | 1 cup (0.3 mg) | 12% |
| Grapes — potassium | 1 cup (288 mg) | 6% |
| Purple grape juice (100%, unsweetened) | 8 oz (~100 mg polyphenols) | — |
| Red wine (5 oz, varies by varietal) | 5 oz (~100–200 mg polyphenols, alcohol caveats) | — |
| Raisins | ¼ cup (concentrated sugars + polyphenols) | — |
Red grapes, raw
- Amount
- 1 cup (151 g, 104 kcal)
- %DV
- —
Black grapes, raw (higher anthocyanin)
- Amount
- 1 cup (~110 kcal)
- %DV
- —
Grapes — vitamin C
- Amount
- 1 cup (4.8 mg)
- %DV
- 5%
Grapes — manganese
- Amount
- 1 cup (0.3 mg)
- %DV
- 12%
Grapes — potassium
- Amount
- 1 cup (288 mg)
- %DV
- 6%
Purple grape juice (100%, unsweetened)
- Amount
- 8 oz (~100 mg polyphenols)
- %DV
- —
Red wine (5 oz, varies by varietal)
- Amount
- 5 oz (~100–200 mg polyphenols, alcohol caveats)
- %DV
- —
Raisins
- Amount
- ¼ cup (concentrated sugars + polyphenols)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
What is the difference between grape seed extract and resveratrol?⌄
Grape seed extract is rich in oligomeric proanthocyanidins, while resveratrol is a specific stilbene found mostly in grape skins. They are distinct compounds with overlapping but different mechanisms.
How much grape seed extract should I take?⌄
Most studies use 100-300 mg per day of a high-OPC standardized extract. Higher doses up to 600 mg have been used in trials without notable safety issues.
Does grape seed extract lower blood pressure?⌄
Trials suggest modest reductions in blood pressure, particularly systolic, in people with hypertension or metabolic syndrome. The effect is typically a few mmHg.
Can I take grape seed extract with blood thinners?⌄
Use caution. Grape polyphenols have mild antiplatelet effects and may compound bleeding risk. Consult your clinician first.
Is grape seed extract safe long-term?⌄
Trials lasting several months show good tolerability. Long-term safety beyond a year is less well studied but no serious concerns have emerged.
References by claim
Blood pressure (mild-to-moderate elevation)
Chronic venous insufficiency (leg symptoms)
Pilot study, GSPE + CVI 4D flow MRI (Sasaki et al.) — PubMed — Phytotherapy Research (2022) link
Skin elasticity and photo-aging
NCCIH Grape Seed Extract Fact Sheet — NCCIH (2024) link
Other references
USDA FoodData Central — Grapes, red or green — USDA (2024) link
Track Grape with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.
